Skip to main content
Premium Trial:

Request an Annual Quote

Cavan Redmond

Cavan Redmond has joined the board of OncoCyte as an independent member. He was most recently the CEO of WebMD Health, where he was also a board member. Before that he was group president at Pfizer, and he has held various positions at Wyeth, including president of the consumer healthcare division. 

The Scan

NFTs for Genome Sharing

Nature News writes that non-fungible tokens could be a way for people to profit from sharing genomic data.

Wastewater Warning System

Time magazine writes that cities and college campuses are monitoring sewage for SARS-CoV-2, an approach officials hope lasts beyond COVID-19.

Networks to Boost Surveillance

Scientific American writes that new organizations and networks aim to improve the ability of developing countries to conduct SARS-CoV-2 genomic surveillance.

Genome Biology Papers on Gastric Cancer Epimutations, BUTTERFLY, GUNC Tool

In Genome Biology this week: recurrent epigenetic mutations in gastric cancer, correction tool for unique molecular identifier-based assays, and more.